THERAVANCE INC - COMMON STOCK (THRX)

CUSIP: 88338T104

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / COMMON STOCK
Total 13F shares
95,292,492
Share change
+2,004,259
Total reported value
$1,628,931,922
Put/Call ratio
181%
Price per share
$17.09
Number of holders
118
Value change
+$14,515,010
Number of buys
56
Number of sells
82

Quarterly Holders Quick Answers

What is CUSIP 88338T104?
CUSIP 88338T104 identifies THRX - THERAVANCE INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAVANCE INC - COMMON STOCK (THRX) as of Q3 2014

As of 30 Sep 2014, THERAVANCE INC - COMMON STOCK (THRX) was held by 118 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 95,292,492 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, FMR LLC, IRIDIAN ASSET MANAGEMENT LLC/CT, Capital World Investors, VANGUARD GROUP INC, OPPENHEIMER FUNDS INC, BlackRock Fund Advisors, State Street Corp, CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD, and Litespeed Management, L.L.C.. This page lists 118 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.